![Xinhua Zhao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xinhua Zhao
Geen lopende functies
Profiel
Dr. Xinhua Zhao is Senior Scientist at Solazyme, Inc.
Dr. Zhao was previously employed as Senior Research Scientist by AureoGen Biosciences, Inc.
He received his graduate degree from Zhejiang University and a doctorate degree from Purdue University.
Eerdere bekende functies van Xinhua Zhao
Bedrijven | Functie | Einde |
---|---|---|
TERRAVIA HOLDINGS INC | Hoofd Techniek/Wetenschap/O&O | - |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Private Equity Analist | 04-02-2010 |
Opleiding van Xinhua Zhao
Purdue University | Doctorate Degree |
Zhejiang University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
TerraVia Holdings, Inc.
![]() TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables TerraVia Holdings, Inc. engaged in the production of food, nutrition, and specialty ingredients from algae. It produced oils, specialty fats, and powdered ingredients using its microalgae-based technology platform. The company was founded by Jonathan S. Wolfson and Harrison F. Dillon on March 31, 2003 and was headquartered in San Francisco, CA. | Consumer Non-Durables |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Health Technology |